Free Trial

Recursion Pharmaceuticals (RXRX) Short Interest Ratio & Short Volume

Recursion Pharmaceuticals logo
$5.41 -0.07 (-1.28%)
Closing price 08/7/2025 04:00 PM Eastern
Extended Trading
$5.42 +0.01 (+0.28%)
As of 08/7/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recursion Pharmaceuticals Short Interest Data

Recursion Pharmaceuticals (RXRX) has a short interest of 115.53 million shares, representing 34.95% of the float (the number of shares available for trading by the public). This marks a -1.60% decrease in short interest from the previous month. The short interest ratio (days to cover) is 4.2, indicating that it would take 4.2 days of the average trading volume of 29.91 million shares to cover all short positions.

Current Short Interest
115,530,000 shares
Previous Short Interest
117,410,000 shares
Change Vs. Previous Month
-1.60%
Dollar Volume Sold Short
$603.07 million
Short Interest Ratio
4.2 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
406,495,000 shares
Float Size
330,560,000 shares
Short Percent of Float
34.95%
Today's Trading Volume
14,211,162 shares
Average Trading Volume
29,913,712 shares
Today's Volume Vs. Average
48%
Short Selling Recursion Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Recursion Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

RXRX Short Interest Over Time

RXRX Days to Cover Over Time

RXRX Percentage of Float Shorted Over Time

Recursion Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/2025115,530,000 shares $603.07 million -1.6%35.0%4.2 $5.22
6/30/2025117,410,000 shares $594.09 million -2.2%35.5%4.5 $5.06
6/15/2025120,080,000 shares $590.79 million +10.1%38.6%5 $4.92
5/31/2025109,030,000 shares $457.93 million +4.6%35.1%4.9 $4.20
5/15/2025104,220,000 shares $442.94 million +11.9%33.5%4.9 $4.25
4/30/202593,120,000 shares $520.54 million -1.5%30.3%3.7 $5.59
4/15/202594,520,000 shares $533.09 million +6.8%30.9%3.8 $5.64
3/31/202588,500,000 shares $468.17 million +2.4%28.9%3.8 $5.29
3/15/202586,420,000 shares $548.77 million +7.1%28.3%3.8 $6.35
2/28/202580,720,000 shares $606.21 million +7.0%26.4%3.5 $7.51
2/15/202575,450,000 shares $794.49 million +18.4%25.4%3.5 $10.53
1/31/202563,750,000 shares $461.55 million -6.1%19.7%3.9 $7.24
1/15/202567,860,000 shares $435.66 million -8.0%21.0%5.2 $6.42
12/31/202473,740,000 shares $498.48 million +9.9%22.8%6.6 $6.76
12/15/202467,100,000 shares $466.35 million -1.1%20.7%7.2 $6.95
11/30/202467,850,000 shares $479.70 million +5.1%22.4%8.8 $7.07
11/15/202464,570,000 shares $398.72 million +3.4%21.3%10.9 $6.18
10/31/202462,430,000 shares $394.56 million +5.0%28.0%12.7 $6.32
10/15/202459,440,000 shares $396.46 million -5.0%26.2%12.2 $6.67
9/30/202462,580,000 shares $412.40 million +5.8%27.9%12.3 $6.59
9/15/202459,160,000 shares $388.68 million +5.6%26.5%10.2 $6.57
8/31/202456,030,000 shares $407.90 million +3.5%26.0%9.9 $7.28
8/15/202454,150,000 shares $362.26 million +7.5%25.1%9.6 $6.69
7/31/202450,370,000 shares $413.03 million +2.1%24.7%8.8 $8.20
7/15/202449,330,000 shares $404.51 million +9.8%24.8%8.9 $8.20
6/30/202444,920,000 shares $336.90 million 0.0%23.6%8.5 $7.50
6/15/202444,930,000 shares $416.05 million +3.0%26.5%9.6 $9.26
5/31/202443,640,000 shares $361.34 million +3.0%26.7%8.6 $8.28
5/15/202442,370,000 shares $424.12 million +4.6%26.1%7.3 $10.01
4/30/202440,500,000 shares $316.71 million +4.7%25.0%6.5 $7.82
4/15/202438,700,000 shares $301.47 million -2.7%26.4%6.2 $7.79
3/31/202439,760,000 shares $396.41 million -8.6%27.1%5.7 $9.97
3/15/202443,520,000 shares $488.29 million +1.6%29.7%6.2 $11.22
2/29/202442,820,000 shares $576.36 million +12.0%29.2%6.4 $13.46
2/15/202438,240,000 shares $475.32 million -0.1%26.1%6 $12.43
1/31/202438,270,000 shares $360.12 million +0.5%25.2%7.1 $9.41
1/15/202438,090,000 shares $425.08 million +2.8%25.1%7.3 $11.16
12/31/202337,040,000 shares $365.21 million +0.1%24.4%8.1 $9.86
12/15/202337,020,000 shares $359.09 million +3.1%24.4%9.2 $9.70
11/30/202335,920,000 shares $246.05 million +1.2%23.9%9.1 $6.85
Crypto bros: Meet your replacement (Ad)

Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.

Now he’s revealing the entire thing… FREE.
11/15/202335,500,000 shares $254.89 million +7.4%23.6%9.6 $7.18
10/31/202333,050,000 shares $174.50 million +3.8%23.9%9.3 $5.28
10/15/202331,850,000 shares $203.20 million +3.6%23.0%8.5 $6.38
9/30/202330,750,000 shares $235.24 million +26.3%22.2%4.6 $7.65
9/15/202324,340,000 shares $208.59 million +5.6%17.7%3.8 $8.57
8/31/202323,040,000 shares $200.45 million +11.8%17.6%3.8 $8.70
8/15/202320,610,000 shares $189.41 million +4.8%15.8%3.3 $9.19
7/31/202319,670,000 shares $277.74 million -0.3%16.6%3.4 $14.12
7/15/202319,720,000 shares $234.67 million +6.4%16.7%3.8 $11.90
6/30/202318,540,000 shares $138.49 million -5.0%15.7%8.9 $7.47
6/15/202319,520,000 shares $181.54 million +5.7%16.5%9.7 $9.30
5/31/202318,460,000 shares $161.89 million -7.7%15.8%9.9 $8.77
5/15/202320,000,000 shares $112 million -2.2%17.3%12.4 $5.60
4/30/202320,440,000 shares $97.50 million +2.2%17.8%18.4 $4.77
4/15/202320,000,000 shares $118.80 million +0.9%17.4%19.6 $5.94
3/31/202319,830,000 shares $132.27 million +4.3%17.3%20.3 $6.67
3/15/202319,020,000 shares $142.27 million +8.1%16.6%19 $7.48
2/28/202317,600,000 shares $143.44 million +1.7%15.4%16.4 $8.15
2/15/202317,310,000 shares $146.10 million -3.1%15.2%15.3 $8.44
1/31/202317,870,000 shares $148.86 million +2.2%16.7%14.4 $8.33
1/15/202317,480,000 shares $152.08 million +4.2%15.1%14 $8.70
12/30/202216,780,000 shares $129.37 million +17.8%14.4%13.9 $7.71
12/15/202214,240,000 shares $120.61 million -4.4%12.2%11.9 $8.47
11/30/202214,890,000 shares $139.97 million -0.2%13.5%11.9 $9.40
11/15/202214,920,000 shares $176.95 million -5.6%13.6%12.8 $11.86
10/31/202215,800,000 shares $166.69 million +1.6%19.3%14.1 $10.55
10/15/202215,550,000 shares $163.12 million -3.9%18.4%14.4 $10.49
9/30/202216,180,000 shares $172.16 million +12.4%19.2%14.8 $10.64
9/15/202214,390,000 shares $188.65 million -1.4%17.1%12.2 $13.11
8/31/202214,590,000 shares $153.34 million -7.6%17.4%14.3 $10.51
8/15/202215,790,000 shares $204.64 million -5.8%18.9%15.6 $12.96
7/31/202216,770,000 shares $141.87 million +4.9%20.2%16.6 $8.46
7/15/202215,990,000 shares $135.92 million +11.7%19.3%15.4 $8.50
6/30/202214,310,000 shares $116.48 million +3.0%17.3%13 $8.14
6/15/202213,890,000 shares $92.79 million -0.9%16.7%12.9 $6.68
5/31/202214,020,000 shares $85.80 million +3.4%17.1%12.5 $6.12
5/15/202213,560,000 shares $76.48 million -3.0%16.5%11.3 $5.64
4/30/202213,980,000 shares $86.68 million +0.4%17.1%12.1 $6.20
4/15/202213,920,000 shares $103.84 million -5.6%17.2%11.9 $7.46
3/31/202214,740,000 shares $105.54 million -8.2%16.9%12.7 $7.16
3/15/202216,060,000 shares $100.38 million -1.6%18.7%13.3 $6.25
2/28/202216,320,000 shares $178.70 million +5.0%19.0%11.1 $10.95
2/15/202215,550,000 shares $185.05 million +6.4%17.9%10.4 $11.90
1/31/202214,620,000 shares $173.10 million +5.6%16.7%9.3 $11.84
1/15/202213,840,000 shares $191.13 million +3.3%15.8%8.7 $13.81
12/31/202113,400,000 shares $229.54 million +20.8%15.3%8.5 $17.13
12/15/202111,090,000 shares $219.03 million +4.0%12.6%7.3 $19.75
11/30/202110,660,000 shares $203.82 million -2.8%12.8%9.4 $19.12
11/15/202110,970,000 shares $205.69 million -5.5%13.2%12 $18.75
10/29/202111,610,000 shares $222.33 million -10.8%14.0%15.7 $19.15
Crypto bros: Meet your replacement (Ad)

Larry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% worldwide. Now he’s applying the same expertise to the Bitcoin market. His system tracks 19 indicators to find quick Bitcoin profit opportunities.

Now he’s revealing the entire thing… FREE.
10/15/202113,010,000 shares $247.71 million +8.5%15.7%21.3 $19.04
9/30/202111,990,000 shares $275.89 million +31.9%14.5%24.4 $23.01
9/15/20219,090,000 shares $217.71 million +25.2%12.0%18.9 $23.95
8/31/20217,260,000 shares $183.10 million +19.0%9.6%16.5 $25.22
8/13/20216,100,000 shares $137.07 million No Change7.6%15.2 $22.47

RXRX Short Interest - Frequently Asked Questions

What is Recursion Pharmaceuticals' current short interest?

Short interest is the volume of Recursion Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 15th, investors have sold 115,530,000 shares of RXRX short. 34.95% of Recursion Pharmaceuticals' shares are currently sold short. Learn More on Recursion Pharmaceuticals' current short interest.

What is a good short interest ratio for Recursion Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. RXRX shares currently have a short interest ratio of 4.0. Learn More on Recursion Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Recursion Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Recursion Pharmaceuticals: Mirae Asset Securities USA Inc., Jane Street Group LLC, Simplex Trading LLC, and National Bank of Canada FI. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Recursion Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 34.95% of Recursion Pharmaceuticals' floating shares are currently sold short.

Is Recursion Pharmaceuticals' short interest increasing or decreasing?

Recursion Pharmaceuticals saw a decline in short interest in July. As of July 15th, there was short interest totaling 115,530,000 shares, a decline of 1.6% from the previous total of 117,410,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Recursion Pharmaceuticals' float size?

Recursion Pharmaceuticals currently has issued a total of 406,495,000 shares. Some of Recursion Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Recursion Pharmaceuticals currently has a public float of 330,560,000 shares.

How does Recursion Pharmaceuticals' short interest compare to its competitors?

34.95% of Recursion Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Recursion Pharmaceuticals: BridgeBio Pharma, Inc. (10.19%), Verona Pharma PLC American Depositary Share (4.77%), Blueprint Medicines Corporation (5.95%), Roivant Sciences Ltd. (10.56%), Grifols, S.A. (0.96%), Legend Biotech Corporation Sponsored ADR (4.57%), Elanco Animal Health Incorporated (4.75%), Revolution Medicines, Inc. (7.33%), Regencell Bioscience Holdings Limited (9.57%), Rhythm Pharmaceuticals, Inc. (7.53%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Recursion Pharmaceuticals stock?

Short selling RXRX is an investing strategy that aims to generate trading profit from Recursion Pharmaceuticals as its price is falling. RXRX shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Recursion Pharmaceuticals?

A short squeeze for Recursion Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of RXRX, which in turn drives the price of the stock up even further.

How often is Recursion Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including RXRX, twice per month. The most recent reporting period available is July, 15 2025.




This page (NASDAQ:RXRX) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners